Clinical Trial Detail

NCT ID NCT01786343
Title Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Decitabine

Age Groups: adult senior

No variant requirements are available.